InnovaRx Innova Health Strategies

G90.519

Complex regional pain syndrome I of unspecified upper limb

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 3 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 13 never code together
G90code
Excludes1
  • dysfunction of the autonomic nervous system due to alcohol (G31.2)G31.2
G90.5code
Excludes1
  • causalgia of lower limb (G57.7-)G57.7-
  • causalgia of upper limb (G56.4-)G56.4-
  • complex regional pain syndrome II of lower limb (G57.7-)G57.7-
  • complex regional pain syndrome II of upper limb (G56.4-)G56.4-
G00-G99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 1
G90.5code
Inclusion terms
  • Reflex sympathetic dystrophy
Index entries leading here 1
  • Syndrome — see also Disease
    • pain — see also Pain
Alongside this code 3 same parent — G90.51
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

ESRD21HCC75

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
G90.51
Block
G89-G99
Siblings
3

Present FY2024–FY2027.